Synthesize
2 known investors
Synthesize develops generative AI models that simulate human tissue responses to drugs and diseases for clinical trial design. The company helps biotech and pharmaceutical development teams de-risk trials, identify biomarkers, and extend early-phase data by generating synthetic patient cohorts.
Founders & leadership
RB
Robert Bradley, PhD
JL
Jeff Leek, PhD
AW
Alice Walsh, PhD
GK
Gregory Koytiger, PhD
AB
Ariel Brumbaugh, PhD
SS
Stein Setvik
LR
Liza Ray, MBA
Investors · 2
In the news
- Synthesize Bio Secures $10 Million Seed Round to Advance Biological Foundation Models | Venture Capitalventurecapital.com · 2025
- Synthesize Bio Raises $10M Seed for Generative Geno… | StartupHub.aistartuphub.ai · 2025
- Synthesize Bio Launches with $10M Seed Fundingfinsmes.com · 2025